Cargando…

A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection

Currently there are no specific treatments available for acute dengue infection. We considered that rupatadine, a platelet-activating factor receptor inhibitor, might modulate dengue-associated vascular leak. The effects of rupatadine were assessed in vitro, and in a dengue model, which showed that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malavige, Gathsaurie Neelika, Wijewickrama, Ananda, Fernando, Samitha, Jeewandara, Chandima, Ginneliya, Anushka, Samarasekara, Supun, Madushanka, Praveen, Punchihewa, Chameera, Paranavitane, Shiran, Idampitiya, Damayanthi, Wanigatunga, Chandanie, Dissanayake, Harsha, Prathapan, Shamini, Gomes, Laksiri, Aman, Siti A. B., John, Ashley St., Ogg, Graham S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832788/ https://www.ncbi.nlm.nih.gov/pubmed/29497121 http://dx.doi.org/10.1038/s41598-018-22285-x

Ejemplares similares

Efficacy of rupatadine in reducing the incidence of dengue haemorrhagic fever in patients with acute dengue: A randomised, double blind, placebo-controlled trial
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2022)

Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection
por: Wijeratne, Dulharie T., et al.
Publicado: (2018)

Patterns and causes of liver involvement in acute dengue infection
por: Fernando, Samitha, et al.
Publicado: (2016)

Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2015)

Similarities and differences between the ‘cytokine storms’ in acute dengue and COVID-19
por: Dayarathna, Shashika, et al.
Publicado: (2020)

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Secretory phospholipase A2 in the pathogenesis of acute dengue infection
por: Jeewandara, Chandima, et al.
Publicado: (2016)

Functionality of Dengue Virus Specific Memory T Cell Responses in Individuals Who Were Hospitalized or Who Had Mild or Subclinical Dengue Infection
por: Jeewandara, Chandima, et al.
Publicado: (2015)

Dengue NS1 antigen as a marker of severe clinical disease
por: Paranavitane, Shiran Ajith, et al.
Publicado: (2014)

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection
por: Jayathilaka, Deshni, et al.
Publicado: (2018)

Dysfunctional Innate Immune Responses and Severe Dengue
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2020)

Dengue and COVID-19: two sides of the same coin
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2022)

Urinary leukotrienes and histamine in patients with varying severity of acute dengue
por: Silva, Tehani, et al.
Publicado: (2021)

Platelet Activating Factor Contributes to Vascular Leak in Acute Dengue Infection
por: Jeewandara, Chandima, et al.
Publicado: (2015)

Association of dengue virus‐specific polyfunctional T‐cell responses with clinical disease severity in acute dengue infection
por: Wijeratne, Dulharie T., et al.
Publicado: (2019)

Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses
por: Pushpakumara, Pradeep Darshana, et al.
Publicado: (2020)

Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes
por: Pushpakumara, Pradeep Darshana, et al.
Publicado: (2020)

Phenotype and functionality of follicular helper T cells in patients with acute dengue infection
por: Wijesinghe, Ayesha, et al.
Publicado: (2020)

Adipokine levels and their association with clinical disease severity in patients with dengue
por: Kuruppu, Heshan, et al.
Publicado: (2023)

Adipokine levels and their association with clinical disease severity in patients with dengue
por: Kuruppu, Heshan, et al.
Publicado: (2023)

Suppression of Virus Specific Immune Responses by IL-10 in Acute Dengue Infection
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2013)

Identification of Novel Candidate CD8(+) T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses
por: Pushpakumara, Pradeep Darshana, et al.
Publicado: (2021)

Risk Factors for Elevated Serum Lipopolysaccharide in Acute Dengue and Association with Clinical Disease Severity
por: Shyamali, N. L. Ajantha, et al.
Publicado: (2020)

Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals
por: Pushpakumara, Pradeep D., et al.
Publicado: (2023)

Sphingosine 1-Phosphate in Acute Dengue Infection
por: Gomes, Laksiri, et al.
Publicado: (2014)

Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients
por: Kamaladasa, Achala, et al.
Publicado: (2021)

Changing epidemiology of dengue in Sri Lanka—Challenges for the future
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2021)

Epidemiological and virological factors determining dengue transmission in Sri Lanka during the COVID-19 pandemic
por: Ariyaratne, Dinuka, et al.
Publicado: (2022)

Cellular and Cytokine Correlates of Severe Dengue Infection
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2012)

Genomic and Epidemiological Analysis of SARS-CoV-2 Viruses in Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2021)

Identification of allergens in coconut milk and oil with patients sensitized to coconut milk in Sri Lanka
por: Iddagoda, Janitha, et al.
Publicado: (2022)

Identification of allergens in Artocarpus heterophyllus, Moringa oleifera, Trianthema portulacastrum and Syzygium samarangense
por: Iddagoda, Janitha, et al.
Publicado: (2023)

Viral Load, Clinical Disease Severity and Cellular Immune Responses in Primary Varicella Zoster Virus Infection in Sri Lanka
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2008)

Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Evaluation of the WHO revised criteria for classification of clinical disease severity in acute adult dengue infection
por: Jayaratne, SD, et al.
Publicado: (2012)

Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR
por: Ranasinghe, Diyanath, et al.
Publicado: (2022)

Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222
por: Jayathilaka, Deshni, et al.
Publicado: (2022)

Serum IL-10 as a marker of severe dengue infection
por: Malavige, Gathsaurie Neelika, et al.
Publicado: (2013)

Regional Variation in Dengue Virus Serotypes in Sri Lanka and Its Clinical and Epidemiological Relevance
por: Jayadas, Tibutius T. P., et al.
Publicado: (2021)

Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ahfjpq1hu8sk6qkkanm3fkb65